Phase 3 Medical Communications Limited 11725207 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is other publishing activities Digita Accounts Production Advanced 6.30.9574.0 true 11725207 2023-01-01 2023-12-31 11725207 2023-12-31 11725207 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 11725207 bus:Micro-entities 2023-01-01 2023-12-31 11725207 bus:Audited 2023-01-01 2023-12-31 11725207 bus:FullAccounts 2023-01-01 2023-12-31 11725207 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 11725207 bus:RegisteredOffice 2023-01-01 2023-12-31 11725207 bus:CompanySecretary1 2023-01-01 2023-12-31 11725207 bus:Director1 2023-01-01 2023-12-31 11725207 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 11725207 countries:England 2023-01-01 2023-12-31 11725207 2022-01-01 2022-12-31 11725207 2022-12-31 11725207 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 11725207

Phase 3 Medical Communications Limited

Filleted Financial Statements

for the Year Ended 31 December 2023

 

Phase 3 Medical Communications Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

2

 

Phase 3 Medical Communications Limited

Company Information

Director

Patricia Forsyth

Company secretary

Nicholas Forsyth

Registered office

Suite 9 Yeovil Innovation Centre
Barracks Close
Copse Road
Yeovil
Somerset
BA22 8RN

Accountants

Whites
Chartered Accountants
Suite 9 Yeovil Innovation Centre
Barracks Close
Copse Road
Yeovil
Somerset
BA22 8RN

 

Phase 3 Medical Communications Limited

(Registration number: 11725207)
Balance Sheet as at 31 December 2023

2023
£

2022
£

Fixed assets

278,956

278,956

Current assets

61,651

43,474

Creditors: Amounts falling due within one year

(24,005)

(11,162)

Net current assets

37,646

32,312

 

316,602

311,268

Capital and reserves

316,602

311,268

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Suite 9 Yeovil Innovation Centre
Barracks Close
Copse Road
Yeovil
Somerset
BA22 8RN
England

These financial statements were authorised for issue by the director on 19 September 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 19 September 2024
 

 

Phase 3 Medical Communications Limited

(Registration number: 11725207)
Balance Sheet as at 31 December 2023

.........................................
Patricia Forsyth
Director